Skip to main content
. Author manuscript; available in PMC: 2013 Dec 2.
Published in final edited form as: Clin J Pain. 2012 Feb;28(2):10.1097/AJP.0b013e3182264fe9. doi: 10.1097/AJP.0b013e3182264fe9

TABLE 2.

Change From Baseline in Phantom Limb Pain VAS, Residual Limb Pain VAS, and Paint Tolerance by Treatment

Month Change in Phantom Limb Pain
Change in Residual Limb Pain
Change in Pain Tolerance
Botox L/D Botox L/D Botox L/D
1 −0.8 (0.5) 1.3 (1.0) −3.1 (0.6) −1.6 (0.7) 0.9 (0.5) 0.4 (0.2)
2 −0.9 (0.7) 1.5 (1.3) −3.0 (1.3) −1.9 (0.9) 0.7 (0.3) 0.4 (0.4)
3 −0.3 (0.3) 2.0 (1.7) −4.5 (1.3) −1.1 (1.6) 1.1 (0.7) 0.6 (0.7)
4 −0.5 (0.5) 0.6 (1.8) −4.8 (1.2) −1.9 (1.1) 1.3 (0.8) 0.2 (0.3)
5 −0.8 (0.6) 1.2 (1.5) −4.6 (1.6) −1.1 (1.0) 1.4 (1.1) 0.1 (0.3)
6 −0.5 (0.3) 0.9 (1.0) −4.4 (1.5) −2.8 (1.0) 1.2 (1.1) 0.5 (0.5)

Values presented as mean (SE).

L/D indicates Lidocaine/Depomedrol injection; VAS, visual analog score.